Profile | GDS4284 / 205483_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1759.81 | 82 |
GSM687648 | Patient 402 control | 1965.49 | 83 |
GSM687653 | Patient 403 control | 2062.35 | 84 |
GSM687658 | Patient 404 control | 7070.31 | 96 |
GSM687663 | Patient 411 control | 2391.9 | 86 |
GSM687668 | Patient 422 control | 1989.86 | 84 |
GSM687673 | Patient 424 control | 5334.97 | 94 |
GSM687678 | Patient 425 control | 4125.12 | 92 |
GSM687683 | Patient 427 control | 2165.5 | 85 |
GSM687688 | Patient 428 control | 2729.49 | 88 |
GSM687695 | Patient 441 control | 4552.87 | 93 |
GSM687699 | Patient 443 control | 3025.23 | 89 |
GSM687704 | Patient 444 control | 1981.84 | 84 |
GSM687707 | Patient 448 control | 2090.67 | 85 |
GSM687712 | Patient 449 control | 3237.68 | 90 |
GSM687719 | Patient 450 control | 2793.13 | 88 |
GSM687724 | Patient 451 control | 3270 | 90 |
GSM687728 | Patient 452 control | 1982.33 | 84 |
GSM687646 | Patient 401 treated 24h | 2280.5 | 85 |
GSM687649 | Patient 402 treated 24h | 1561.46 | 80 |
GSM687665 | Patient 411 treated 24h | 2447.8 | 87 |
GSM687651 | Patient 402 treated 4 weeks | 1439.03 | 79 |
GSM687667 | Patient 411 treated 4 weeks | 1586.09 | 80 |
GSM687670 | Patient 422 treated 24h | 2021.36 | 84 |
GSM687671 | Patient 422 treated 4 weeks | 2003.35 | 84 |
GSM687654 | Patient 403 treated 24h | 2158.82 | 85 |
GSM687675 | Patient 424 treated 24h | 4188.33 | 92 |
GSM687685 | Patient 427 treated 24h | 2790.16 | 88 |
GSM687656 | Patient 403 treated 4 weeks | 1890.26 | 83 |
GSM687677 | Patient 424 treated 4 weeks | 6002.08 | 95 |
GSM687687 | Patient 427 treated 4 weeks | 2237.54 | 85 |
GSM687692 | Patient 428 treated 4h | 2927.24 | 88 |
GSM687716 | Patient 449 treated 4h | 3574.36 | 90 |
GSM687722 | Patient 450 treated 4h | 4174.83 | 92 |
GSM687680 | Patient 425 treated 24h | 3861.99 | 91 |
GSM687690 | Patient 428 treated 24h | 2667.5 | 87 |
GSM687700 | Patient 443 treated 24h | 5148.72 | 94 |
GSM687705 | Patient 444 treated 24h | 1993.75 | 84 |
GSM687714 | Patient 449 treated 24h | 3165.74 | 89 |
GSM687721 | Patient 450 treated 24h | 4732.57 | 93 |
GSM687682 | Patient 425 treated 4 weeks | 5660.02 | 94 |
GSM687694 | Patient 428 treated 4 weeks | 3022.46 | 89 |
GSM687702 | Patient 443 treated 4 weeks | 2976.57 | 89 |
GSM687718 | Patient 449 treated 4 weeks | 4709.71 | 93 |
GSM687723 | Patient 450 treated 4 weeks | 2579.01 | 87 |
GSM687661 | Patient 404 treated 4h | 5160.86 | 94 |
GSM687710 | Patient 448 treated 4h | 1870.36 | 83 |
GSM687726 | Patient 451 treated 4h | 3439.58 | 90 |
GSM687730 | Patient 452 treated 4h | 6855.74 | 96 |
GSM687660 | Patient 404 treated 24h | 20829.1 | 98 |
GSM687697 | Patient 441 treated 24h | 5479.95 | 94 |
GSM687709 | Patient 448 treated 24h | 2583.53 | 87 |
GSM687725 | Patient 451 treated 24h | 3520.97 | 91 |
GSM687729 | Patient 452 treated 24h | 2059.82 | 86 |
GSM687727 | Patient 451 treated 4 weeks | 6116.08 | 95 |
GSM687731 | Patient 452 treated 4 weeks | 11707.5 | 98 |